Zwilch inhibitors are chemical compounds designed to specifically inhibit the function of the Zwilch protein, which is an essential component of the kinetochore, a complex of proteins involved in chromosome segregation during cell division. Zwilch is a part of the RZZ (Rod, Zwilch, and ZW10) complex, which plays a key role in the spindle assembly checkpoint (SAC). This checkpoint ensures that chromosomes are properly aligned and attached to the mitotic spindle before anaphase begins, preventing errors in chromosome segregation that can lead to aneuploidy. Zwilch is critical for recruiting other key kinetochore proteins and for regulating the activity of the SAC, making it a central player in maintaining the accuracy of mitosis.
Inhibitors of Zwilch function by targeting this protein's role within the RZZ complex, potentially disrupting its ability to facilitate proper chromosome alignment and spindle attachment. By inhibiting Zwilch, these compounds interfere with the recruitment of other kinetochore proteins and impair the spindle assembly checkpoint, which can lead to altered mitotic progression. This inhibition can affect the fidelity of chromosome segregation, offering valuable insights into the mechanistic role of Zwilch in mitosis and the overall maintenance of genomic stability. Researchers use Zwilch inhibitors to study the molecular dynamics of kinetochore function and to explore how disruptions in chromosome segregation mechanisms contribute to broader cellular processes. These inhibitors provide a powerful tool for dissecting the complex protein interactions and checkpoints that govern cell division, shedding light on the critical roles that Zwilch and the RZZ complex play in mitotic regulation.
SEE ALSO...
Items 11 to 12 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate might inhibit the expression of Zwilch by acting as a dihydrofolate reductase inhibitor, resulting in the depletion of tetrahydrofolate and subsequent hindrance of thymidylate synthesis. This could lead to a reduction in the expression of genes required for DNA replication and cell cycle progression, such as Zwilch. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate may downregulate Zwilch expression by serving as an HDAC inhibitor, which would increase the acetylation of histones at the Zwilch promoter site. The elevated acetylation levels could cause the promoter to become less accessible to the transcription machinery necessary for Zwilch gene transcription. | ||||||